Role of eosinophils and tumor necrosis factor alpha in interleukin-25-mediated protection from amebic colitis

mBio

Volumn 8, Issue 1, 2017, Pages

  Noor, Zannatun ^a,c   Watanabe, Koji ^a,b   Abhyankar, Mayuresh M ^a   Burgess, Stacey L ^a   Buonomo, Erica L ^a   Cowardin, Carrie A ^a,d   Petri, William A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c International Centre for Diarrheal Diseases and Research   (Bangladesh)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 25; TUMOR NECROSIS FACTOR; D17WSU104E PROTEIN, MOUSE; IL25 PROTEIN, HUMAN; INTERLEUKIN 17; INTERLEUKIN DERIVATIVE;

AMEBIASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DIARRHEA; ENTAMOEBA HISTOLYTICA; EOSINOPHIL; HUMAN; IMMUNOREGULATION; INFECTION; INTESTINE EPITHELIUM; INTESTINE PROTECTION; MOUSE; MOUSE MODEL; NONHUMAN; PROPHYLAXIS; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; DISEASE MODEL; IMMUNOLOGY; METABOLISM;

ANIMALS; DISEASE MODELS, ANIMAL; DYSENTERY, AMEBIC; ENTAMOEBA HISTOLYTICA; EOSINOPHILS; HUMANS; INTERLEUKIN-17; INTERLEUKINS; MICE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85014812037     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02329-16     Document Type: Article

References (38)

1. Mulatu G, Zeynudin A, Zemene E, Debalke S, Beyene G. 2015. Intestinal parasitic infections among children under five years of age presenting with diarrhoeal diseases to two public health facilities in Hawassa, South Ethiopia. Infect Dis Poverty 4:49. https://doi.org/10.1186/s40249-015-0081-x.
2. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acácio S, Biswas K, O’Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. 2013. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382:209–222. https://doi.org/10.1016/S0140-6736(13)60844-2.
3. Platts-Mills JA, Babji S, Bodhidatta L, Gratz J, Haque R, Havt A, McCormick BJ, McGrath M, Olortegui MP, Samie A, Shakoor S, Mondal D, Lima IF, Hariraju D, Rayamajhi BB, Qureshi S, Kabir F, Yori PP, Mufamadi B, Amour C, Carreon JD, Richard SA, Lang D, Bessong P, Mduma E, Ahmed T, Lima AA, Mason CJ, Zaidi AK, Bhutta ZA, Kosek M, Guerrant RL, Gottlieb M, Miller M, Kang G, Houpt ER, MAL-ED Network Investigators. 2015. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob Health 3:e564–e575. https://doi.org/10.1016/S2214-109X(15)00151-5.
4. Haque R, Duggal P, Ali IM, Hossain MB, Mondal D, Sack RB, Farr BM, Beaty TH, Petri WA. 2002. Innate and acquired resistance to amebiasis in Bangladeshi children. J Infect Dis 186:547–552. https://doi.org/10.1086/341566.
5. Marie C, Petri WA. 2014. Regulation of virulence of Entamoeba histolytica. Annu Rev Microbiol 68:493–520. https://doi.org/10.1146/annurev -micro-091313-103550.
6. Wieser A, Guggenberger C, Pritsch M, Heesemann J, Schubert S. 2011. A novel ex vivo set-up for dynamic long-term characterization of processes on mucosal interfaces by confocal imaging and simultaneous cytokine measurements. Cell Microbiol 13:742–751. https://doi.org/10.1111/j.1462-5822.2011.01573.x.
7. Haque R, Mondal D, Kirkpatrick BD, Akther S, Farr BM, Sack RB, Petri WA. 2003. Epidemiologic and clinical characteristics of acute diarrhea with emphasis on Entamoeba histolytica infections in preschool children in an urban slum of Dhaka, Bangladesh. Am J Trop Med Hyg 69:398–405.
8. Peterson KM, Guo X, Elkahloun AG, Mondal D, Bardhan PK, Sugawara A, Duggal P, Haque R, Petri WA. 2011. The expression of REG 1A and REG 1B is increased during acute amebic colitis. Parasitol Int 60:296–300. https://doi.org/10.1016/j.parint.2011.04.005.
9. Guo X, Stroup SE, Houpt ER. 2008. Persistence of Entamoeba histolytica infection in CBA mice owes to intestinal IL-4 production and inhibition of protective IFN-gamma. Mucosal Immunol 1:139–146. https://doi.org/10.1038/mi.2007.18.
10. Moonah SN, Abhyankar MM, Haque R, Petri WA. 2014. The macrophage migration inhibitory factor homolog of Entamoeba histolytica binds to and immunomodulates host macrophages. Infect Immun 82:3523–3530. https://doi.org/10.1128/IAI.01812-14.
11. Kissoon-Singh V, Moreau F, Trusevych E, Chadee K. 2013. Entamoeba histolytica exacerbates epithelial tight junction permeability and proinflammatory responses in Muc2(-/-) mice. Am J Pathol 182:852–865. https://doi.org/10.1016/j.ajpath.2012.11.035.
12. Mortimer L, Moreau F, Cornick S, Chadee K. 2015. The NLRP3 inflammasome is a pathogen sensor for invasive Entamoeba histolytica via activation of α 5β1 integrin at the macrophage-amebae intercellular junction. PLoS Pathog 11:e1004887. https://doi.org/10.1371/journal.ppat.1004887.
13. Petri WA, Smith RD, Schlesinger PH, Murphy CF, Ravdin JI. 1987. Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica. J Clin Invest 80:1238–1244. https://doi.org/10.1172/JCI113198.
14. Mortimer L, Moreau F, Cornick S, Chadee K. 2014. Gal-lectin-dependent contact activates the inflammasome by invasive Entamoeba histolytica. Mucosal Immunol 7:829–841. https://doi.org/10.1038/mi.2013.100.
15. Moonah SN, Jiang NM, Petri WA. 2013. Host immune response to intestinal amebiasis. PLoS Pathog 9:e1003489. https://doi.org/10.1371/journal.ppat.1003489.
16. Zhang Z, Mahajan S, Zhang X, Stanley SL. 2003. Tumor necrosis factor alpha is a key mediator of gut inflammation seen in amebic colitis in human intestine in the SCID mouse-human intestinal xenograft model of disease. Infect Immun 71:5355–5359. https://doi.org/10.1128/IAI.71.9.5355-5359.2003.
17. Peterson KM, Shu J, Duggal P, Haque R, Mondal D, Petri WA. 2010. Association between TNF-alpha and Entamoeba histolytica diarrhea. Am J Trop Med Hyg 82:620–625. https://doi.org/10.4269/ajtmh.2010.09 -0493.
18. Abdel-Hafeez EH, Belal US, Abdellatif MZM, Naoi K, Norose K. 2013. Breast-feeding protects infantile diarrhea caused by intestinal protozoan infections. Korean J Parasitol 51:519–524. https://doi.org/10.3347/kjp.2013.51.5.519.
19. Saenz SA, Taylor BC, Artis D. 2008. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev 226:172–190. https://doi.org/10.1111/j.1600-065X.2008.00713.x.
20. Fina D, Franzè E, Rovedatti L, Corazza GR, Biancone L, Sileri PP, Sica G, MacDonald TT, Pallone F, Di Sabatino A, Monteleone G. 2011. Interleukin-25 production is differently regulated by TNF-α and TGF-β1 in the human gut. Mucosal Immunol 4:239–244. https://doi.org/10.1038/mi.2010.68.
21. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, Menon S, Clifford T, Hunte B, Lesley R, Muchamuel T, Hurst SD, Zurawski G, Leach MW, Gorman DM, Rennick DM. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15:985–995. https://doi.org/10.1016/S1074-7613(01)00243-6.
22. Zaph C, Du Y, Saenz SA, Nair MG, Perrigoue JG, Taylor BC, Troy AE, Kobuley DE, Kastelein RA, Cua DJ, Yu Y, Artis D. 2008. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med 205:2191–2198. https://doi.org/10.1084/jem.20080720.
23. Noor Z, Burgess SL, Watanabe K, Petri WA. 2016. Interleukin-25 mediated induction of angiogenin-4 is interleukin-13 dependent. PLoS One 11: e0153572. https://doi.org/10.1371/journal.pone.0153572.
24. Buonomo EL, Cowardin CA, Wilson MG, Saleh MM, Pramoonjago P, Petri WA. 2016. Microbiota-regulated IL-25 increases eosinophil number to provide protection during Clostridium difficile infection. Cell Rep 16: 432–443. https://doi.org/10.1016/j.celrep.2016.06.007.
25. López-Osuna M, Velázquez JR, Kretschmer RR. 1997. Does the eosinophil have a protective role in amebiasis? Mem Inst Oswaldo Cruz 92(Suppl 2):237–240. https://doi.org/10.1590/S0074-02761997000800035.
26. Guo X, Roberts MR, Becker SM, Podd B, Zhang Y, Chua SC, Myers MG, Duggal P, Houpt ER, Petri WA. 2011. Leptin signaling in intestinal epithelium mediates resistance to enteric infection by Entamoeba histolytica. Mucosal Immunol 4:294–303. https://doi.org/10.1038/mi.2010.76.
27. Gilchrist CA, Petri SE, Schneider BN, Reichman DJ, Jiang N, Begum S, Watanabe K, Jansen CS, Elliott KP, Burgess SL, Ma JZ, Alam M, Kabir M, Haque R, Petri WA. 2016. Role of the gut microbiota of children in diarrhea due to the protozoan parasite Entamoeba histolytica. J Infect Dis 213:1579–1585. https://doi.org/10.1093/infdis/jiv772.
28. Burgess SL, Buonomo E, Carey M, Cowardin C, Naylor C, Noor Z, Wills-Karp M, Petri WA. 2014. Bone marrow dendritic cells from mice with an altered microbiota provide interleukin 17A-dependent protection against Entamoeba histolytica colitis. mBio 5:e01817-14. https://doi.org/10.1128/mBio.01817-14.
29. Salmon-Ehr V, Ramont L, Godeau G, Birembaut P, Guenounou M, Bernard P, Maquart FX. 2000. Implication of interleukin-4 in wound healing. Lab Invest 80:1337–1343. https://doi.org/10.1038/labinvest.3780141.
30. Feng YH, Mao H. 2012. Expression and preliminary functional analysis of Siglec-F on mouse macrophages. J Zhejiang Univ Sci B 13:386–394. https://doi.org/10.1631/jzus.B1100218.
31. Gicheva N, Macauley MS, Arlian BM, Paulson JC, Kawasaki N. 2016. Siglec-F is a novel intestinal M cell marker. Biochem Biophys Res Commun 479:1–4. https://doi.org/10.1016/j.bbrc.2016.08.055.
32. Cowardin CA, Buonomo EL, Saleh MM, Wilson MG, Burgess SL, Kuehne SA, Schwan C, Eichhoff AM, Koch-Nolte F, Lyras D, Aktories K, Minton NP, Petri WA. 2016. The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia. Nat Microbiol 1:16108. https://doi.org/10.1038/nmicrobiol.2016.108.
33. Naylor C, Burgess S, Madan R, Buonomo E, Razzaq K, Ralston K, Petri WA. 2014. Leptin receptor mutation results in defective neutrophil recruitment to the colon during Entamoeba histolytica infection. mBio 5:e02046-14. https://doi.org/10.1128/mBio.02046-14.
34. Tanyuksel M, Petri WA. 2003. Laboratory diagnosis of amebiasis. Clin Microbiol Rev 16:713–729. https://doi.org/10.1128/CMR.16.4.713-729.2003.
35. Chen Z, Andreev D, Oeser K, Krljanac B, Hueber A, Kleyer A, Voehringer D, Schett G, Bozec A. 2016. Th2 and eosinophil responses suppress inflammatory arthritis. Nat Commun 7:11596. https://doi.org/10.1038/ncomms11596.
36. Cheung PFY, Wong CK, Ip WK, Lam CWK. 2006. IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation. Allergy 61:878–885. https://doi.org/10.1111/j.1398-9995.2006.01102.x.
37.  T cells. J Immunol 169:4496–4503. https://doi.org/10.4049/jimmunol.169.8.4496.
38. Madan R, Guo X, Naylor C, Buonomo EL, Mackay D, Noor Z, Concannon P, Scully KW, Pramoonjago P, Kolling GL, Warren CA, Duggal P, Petri WA. 2014. Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitis. Infect Immun 82:341–349. https://doi.org/10.1128/IAI.00972-13.